Accès gratuit
Numéro |
Med Sci (Paris)
Volume 39, Numéro 3, Mars 2023
Néphrologie pédiatrique : de grandes avancées et un futur rempli d’espoir
|
|
---|---|---|
Page(s) | 253 - 261 | |
Section | M/S Revues | |
DOI | ||
Publié en ligne | 21 mars 2023 |
- Levy M, Feingold J. Estimating prevalence in single-gene kidney diseases progressing to renal failure. Kidney Int 2000 ; 58 : 925–943.
- Gahl WA, Thoene JG, Schneider JA. Cystinosis. N Engl J Med 2002 ; 347 : 111–121.
- Gahl WA, Schneider JA, Aula P. Lysosomal transport disorders : cystinosis and sialic acid storage disorders. In: The Metabolic and Molecular Basis of Inherited Disease. eds Scriver CR, Beaudet AL, Sly WS, Valle D. 7th ed. 1995 : 3763–97.
- Haffner D, Weinfurth A, Manz Fet al. Long-term outcome of paediatric patients with hereditary tubular disorders. Nephron 1999 ; 83 : 250–260.
- Lemire J, Kaplan BS. The various renal manifestations of the nephropathic form of cystinosis. Am J Nephrol 1984 ; 4 : 81–85.
- Langman CB, Moore ES, Thoene JG, Schneider JA. Renal failure in a sibship with late-onset cystinosis. J Pediatr 1985 ; 107 : 755–756.
- Lietman PS, Frazier PD, Wong VG. et al. Adult cystinosis-a benign disorder. Am J Med 1966; 40 : 511–7.
- Gahl WA, Reed GF, Thoene JGet al. Cysteamine therapy for children with nephropathic cystinosis. N Engl J Med 1987 ; 316 : 971–977.
- Dohil R, Fidler M, Gangoiti JAet al. Twice-daily cysteamine bitartrate therapy for children with cystinosis. J Pediatr 2010 ; 156: 71–5 e1–3.
- Schneider JA. Approval of cysteamine for patients with cystinosis. Pediatr Nephrol 1995 ; 9 : 254.
- The Cystinosis Collaborative Research Group. Linkage of the gene for cystinosis to markers on the short arm of chromosome 17. Nat Genet 1995 ; 10 : 246–248.
- Town M, Jean G, Cherqui Set al. A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis. Nat Genet 1998 ; 18 : 319–324.
- Cherqui S, Kalatzis V, Trugnan G, Antignac C. The targeting of cystinosin to the lysosomal membrane requires a tyrosine-based signal and a novel sorting motif. J Biol Chem 2001 ; 276 : 13314–13321.
- Kalatzis V, Cherqui S, Antignac C, Gasnier B. Cystinosin, the protein defective in cystinosis, is a H(+)-driven lysosomal cystine transporter. Embo J 2001 ; 20 : 5940–5949.
- Zhai Y, Heijne WH, Smith DW, Saier MH, Jr.. Homologues of archaeal rhodopsins in plants, animals and fungi : structural and functional predications for a putative fungal chaperone protein. Biochim Biophys Acta 2001 ; 1511 : 206–223.
- Kalatzis V, Nevo N, Cherqui Set al. Molecular pathogenesis of cystinosis : effect of CTNS mutations on the transport activity and subcellular localization of cystinosin. Hum Mol Genet 2004 ; 13 : 1361–1371.
- Gaide Chevronnay HP, Janssens V, Van Der Smissen P, et al., A mouse model suggests two mechanisms for thyroid alterations in infantile cystinosis: decreased thyroglobulin synthesis due to endoplasmic reticulum stress/unfolded protein response and impaired lysosomal processing. Endocrinology 2015 ; 156 : 2349–2364.
- Forestier L, Jean G, Attard Met al. Molecular characterization of CTNS deletions in nephropathic cystinosis : development of a PCR-based detection assay. Am J Hum Genet 1999 ; 65 : 353–359.
- Cherqui S, Kalatzis V, Forestier L, et al. Identification and characterisation of the murine homologue of the gene responsible for cystinosis. Ctns. BMC Genomics 2000 ; 1 : 2.
- Dufier JL, Dhermy P, Gubler MC, et al. Ocular changes in long-term evolution of infantile cystinosis. Ophthalmic Paediatr Genet 1987 ; 8 : 131–137.
- Nevo N, Chol M, Bailleux A, et al. Renal phenotype of the cystinosis mouse model is dependent upon genetic background. Nephrol Dial Transplant 2010 ; 25 : 1059–1066.
- Syres K, Harrison F, Tadlock M, et al. Successful treatment of the murine model of cystinosis using bone marrow cell transplantation. Blood 2009 ; 114 : 2542–2552.
- Yeagy BA, Harrison F, Gubler MC, et al. Kidney preservation by bone marrow cell transplantation in hereditary nephropathy. Kidney Int 2011 ; 79 : 1198–1206.
- Goodman S, Naphade S, Khan M, et al. Macrophage polarization impacts tunneling nanotube formation and intercellular organelle trafficking. Sci Rep 2019 ; 9 : 14529.
- Naphade S, Sharma J, Gaide Chevronnay HP, et al. Brief reports : lysosomal cross-correction by hematopoietic stem cell-derived macrophages via tunneling nanotubes. Stem Cells 2015 ; 33 : 301–309.
- Gaide Chevronnay HP, Janssens V, Van Der Smissen P, et al. Hematopoietic Stem Cells Transplantation Can Normalize Thyroid Function in a Cystinosis Mouse Model. Endocrinology 2016 ; 157 : 1363–1371.
- Rocca CJ, Kreymerman A, Ur SN, et al. Treatment of Inherited Eye Defects by Systemic Hematopoietic Stem Cell Transplantation. Invest Ophthalmol Vis Sci 2015 ; 56 : 7214–7223.
- Haschemi A, Kosma P, Gille L, et al. The sedoheptulose kinase CARKL directs macrophage polarization through control of glucose metabolism. Cell Metab 2012 ; 15 : 813–826.
- Goodman S, Khan M, Sharma J, et al. Deficiency of the sedoheptulose kinase (Shpk) does not alter the ability of hematopoietic stem cells to rescue cystinosis in the mouse model. Mol Genet Metab 2021; 134 : 309–16.
- Elmonem MA, Veys K, Oliveira Arcolino F, et al. Allogeneic HSCT transfers wild-type cystinosin to nonhematological epithelial cells in cystinosis : First human report. Am J Transplant 2018 ; 18 : 2823–2828.
- Cartier N, Hacein-Bey-Abina S, Bartholomae CC, et al. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 2009 ; 326 : 818–823.
- Harrison F, Yeagy BA, Rocca CJ, et al. Hematopoietic stem cell gene therapy for the multisystemic lysosomal storage disorder cystinosis. Mol Ther 2013 ; 21 : 433–444.
- Yannaki E, Karponi G, Zervou F, et al. Hematopoietic stem cell mobilization for gene therapy : superior mobilization by the combination of granulocyte-colony stimulating factor plus plerixafor in patients with beta-thalassemia major. Hum Gene Ther 2013 ; 24 : 852–860.
- Cherqui S, Sevin C, Hamard G, et al. Intralysosomal cystine accumulation in mice lacking cystinosin, the protein defective in cystinosis. Mol Cell Biol 2002 ; 22 : 7622–7632.
Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.
Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.
Le chargement des statistiques peut être long.